Taking people in Olaszország1. fázis
A Phase 1b Open-Label Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-cancer Agents in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
Key facts
- Where
- Bergamo, Bologna, Brescia és Milan, OlaszországSee the 4 sites
- Phase
- 1. fázis
Where in Olaszország
- Azienda Socio Sanitaria Territoriale Papa Giovanni XXIIIBergamo, OlaszországTaking people
- Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere ScientificoBologna, OlaszországTaking people
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaBrescia, OlaszországTaking people
- Istituto Europeo di Oncologia s.r.lMilan, OlaszországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- ADC Therapeutics SA
- Trial code
- NCT04970901EU 2024-512089-32-00
- Record updated
- 2026. szeptember 15.